The subject invention concerns compositions and methods for blocking cancer cell growth or proliferation and/or inducing cancer cell death. Compositions of the present invention are compounds that inhibit Rho-protein associated kinase function. Compounds of the invention include piperazinyl pyridines, piperazinylmethyl pyridines, piperazinyl ureas and carbamates, piperazinyl pyridines and quinoilines (including isoquinliones) as well as piperazinyl (including piperazinylmethyl) pyridines and quinolines (including isoquinolines). Compounds of the invention disrupt Rho-kinase activation and function and significantly inhibit tumor cell growth and induce tumor cell death
The present invention concerns the use of the protein RhoB and its variants to inhibit cancer cell g...
The present invention concerns the use of the protein RhoB and its variants to inhibit c...
Disruption of protein kinase signalling pathways is often associated with cancer. TheRhoA/ROCK kinas...
The subject invention concerns compositions and methods for blocking cancer cell growth or prolifera...
The Rho-associated (ROCK) serine/threonine kinases have emerged as central regulators of the actomyo...
The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as prot...
The subject invention concerns compositions and methods for blocking cancer cell growth or prolifera...
The present invention concerns a compound of formula (I), in particular as LIMK and/or ROCK kinases ...
ROCK1 and ROCK2 mediate important processes such as cell migration, invasion and metastasis; making ...
The disclosed modulators of Rb:Raf-1 interactions are potent, selective disruptors of Rb:Raf-1 bindi...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
The Rho kinases (ROCK1 and ROCK2) are highly homologous serine/threonine kinases that act on substra...
Compounds of the substituted pyrazole class as treatments for cancer are reported. A method of treat...
The present invention concerns the use of the protein RhoB and its variants to inhibit cancer cell g...
The present invention concerns the use of the protein RhoB and its variants to inhibit c...
Disruption of protein kinase signalling pathways is often associated with cancer. TheRhoA/ROCK kinas...
The subject invention concerns compositions and methods for blocking cancer cell growth or prolifera...
The Rho-associated (ROCK) serine/threonine kinases have emerged as central regulators of the actomyo...
The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as prot...
The subject invention concerns compositions and methods for blocking cancer cell growth or prolifera...
The present invention concerns a compound of formula (I), in particular as LIMK and/or ROCK kinases ...
ROCK1 and ROCK2 mediate important processes such as cell migration, invasion and metastasis; making ...
The disclosed modulators of Rb:Raf-1 interactions are potent, selective disruptors of Rb:Raf-1 bindi...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
The subject invention concerns materials and methods for inhibiting the Akt/PKB pathway. In one embo...
The Rho kinases (ROCK1 and ROCK2) are highly homologous serine/threonine kinases that act on substra...
Compounds of the substituted pyrazole class as treatments for cancer are reported. A method of treat...
The present invention concerns the use of the protein RhoB and its variants to inhibit cancer cell g...
The present invention concerns the use of the protein RhoB and its variants to inhibit c...
Disruption of protein kinase signalling pathways is often associated with cancer. TheRhoA/ROCK kinas...